ENTRY       D08170                      Drug
NAME        Melatonin (JAN);
            Melatonina (TN);
            Melatobel (TN)
FORMULA     C13H16N2O2
EXACT_MASS  232.1212
MOL_WEIGHT  232.2783
CLASS       Neuropsychiatric agent
             DG01589  Melatonin receptor agonist
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
REMARK      Same as: C01598
            Therapeutic category: 1190
            ATC code: N05CH01
            Product: D08170<JP>
EFFICACY    Anticonvulsant, Cerebroprotective, Sedative-hypnotic, Melatonin receptor agonist
COMMENT     Hormone
            Free oxygen radical scavenger
TARGET      MTNR1 [HSA:4543 4544] [KO:K04285 K04286]
  PATHWAY   hsa04080(4543+4544)  Neuroactive ligand-receptor interaction
            hsa04713(4543+4544)  Circadian entrainment
METABOLISM  Enzyme: CYP1A2 [HSA:1544]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N05 PSYCHOLEPTICS
               N05C HYPNOTICS AND SEDATIVES
                N05CH Melatonin receptor agonists
                 N05CH01 Melatonin
                  D08170  Melatonin (JAN) &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               119  Miscellaneous
                1190  Miscellaneous
                 D08170  Melatonin (JAN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01589  Melatonin receptor agonist
               D08170  Melatonin
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               D08170  Melatonin
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Melatonin
                MTNR1
                 D08170  Melatonin (JAN) &lt;JP&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D08170
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D08170
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D08170
DBLINKS     CAS: 73-31-4
            PubChem: 96024860
            ChEBI: 16796
            PDB-CCD: ML1
            LigandBox: D08170
            NIKKAJI: J5.258B
ATOM        17
            1   C8x C    18.1300  -19.6000
            2   C8y C    18.1300  -18.2000
            3   C8x C    19.3200  -17.5000
            4   C8y C    20.5100  -18.2000
            5   C8y C    20.5100  -19.6000
            6   C8x C    19.3200  -20.3000
            7   C8y C    21.8400  -17.7800
            8   C8x C    22.6800  -18.9000
            9   N4x N    21.8400  -20.0900
            10  O2a O    16.8700  -17.5000
            11  C1a C    15.6800  -18.2000
            12  C1b C    22.2600  -16.4500
            13  C1b C    23.6600  -16.1700
            14  N1b N    24.0800  -14.8400
            15  C5a C    25.4800  -14.5600
            16  C1a C    25.9000  -13.2300
            17  O5a O    26.3900  -15.6100
BOND        18
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 2
            9     8   9 1
            10    5   9 1
            11    2  10 1
            12   10  11 1
            13    7  12 1
            14   12  13 1
            15   13  14 1
            16   14  15 1
            17   15  16 1
            18   15  17 2
///
